Short anagen syndrome: A unique short hair syndrome without any characteristic hair morphological abnormality

Abstract

onychomycosis due to other Candida species have also been reported. 3 C. tropicalis is often isolated from fungus-infected nails in Brazil, but there have been no reports of onychomycosis caused by C. tropicalis in Japan. 4 The risk factors of candidal onychomycosis include congenital mucocutaneous candidiasis, HIV infection, immunosuppressive therapy, peripheral vascular disease and diabetes mellitus. 2 Trauma during farming or hobby gardening may contribute to the onset of finger onychomycosis, whereas no significant risk factor was identified in the patient in the present case. The association of chronic paronychia suggests the involvement of Candida; however, candidal infections are difficult to diagnose in cases without swelling of the nail fold. Although a fungal culture is the gold standard for identifying the causative organism, this examination requires several weeks of incubation and sometimes produces a false-negative result. In addition, several strains of Candida species demonstrate resistance to terbinafine. 5 Therefore, azoles, including itraconazole and fosravuconazole, which exhibit remarkable antifungal activity against Candida species, should be preferentially prescribed to patients with finger onychomycosis.

Short anagen syndrome: A case series and algorithm for diagnosis

“…Concerning the treatment of SAS, topical minoxidil may be effective because it increases the duration of the anagen phase, improves hair length, and prevents telogen effluvium. 3,4 However, treatment with topical minoxidil is controversial as the disease usually resolves spontaneously after puberty and parents need to be reassured about the benign course of the disease. According to our experience, treatment with topical minoxidil represents a potential option when parents desire early therapy, leading to increase in hair density and improvement of the hair length.…”

“…Concerning the treatment of SAS, topical minoxidil may be effective because it increases the duration of the anagen phase, improves hair length, and prevents telogen effluvium 3,4 . However, treatment with topical minoxidil is controversial as the disease usually resolves spontaneously after puberty and parents need to be reassured about the benign course of the disease.…”

“…This condition mostly affects Caucasian patients. Only 4 Asian, 1 Hispanic, and 2 African SAS patients have been reported in the literature 4‐6 . A recent review of pediatric SAS highlights its prevalence in females and the rarity of any underlying pathological findings.…”

“…Only 4 Asian, 1 Hispanic, and 2 African SAS patients have been reported in the literature. [4][5][6] A recent review of pediatric SAS highlights its prevalence in females and the rarity of any underlying pathological findings. Only 2 cases have presented in association with other medical conditions, one with linear scleroderma and another with an occluded lacrimal duct and multiple micronychia.…”